MOYOM, the biotechnology company behind APHRANEL, announced two major milestones in its European strategy: the achievement of European Medical Device Regulation (EU MDR) certification for APHRANEL and the establishment of a strategic scientific collaboration with Expert2Expert (E2E), led by internationally recognized aesthetic surgeon Dr. Patrick Trévidic.
These milestones mark a new phase in MOYOM's long-term commitment to advancing regenerative aesthetics through scientific validation, physician education and international collaboration.
On July 7, APHRANEL achieved EU MDR certification under Regulation (EU) 2017/745, granted by BSI UK, one of the world's most respected Notified Bodies. This certification confirms that APHRANEL meets Europe's highest standards for quality, safety and clinical performance, opening the door not only to the European market but marking a new phase in MOYOM's international expansion.
For MOYOM, regulatory approval is not the destination, but the beginning of a broader scientific journey.
"Obtaining market access is only the first challenge. Earning physicians' confidence is the one that matters most."
Following this milestone, MOYOM initiated a strategic scientific collaboration with Dr. Patrick Trévidic and Expert2Expert (E2E), an independent scientific partner with more than 20 years of experience supporting leading stakeholders in aesthetic medicine.
This collaboration aims to establish a long-term platform for regenerative aesthetics in Europe through anatomical research, advanced cadaver studies, clinical evidence generation, physician education and scientific publications.
Expert2Expert, led by Dr. Patrick Trévidic, will contribute as an independent scientific partner, bringing extensive expertise in anatomy-based education and research while maintaining full scientific independence.
This partnership represents a shared commitment to evidence-based innovation while maintaining the independence of all scientific activities.
Dr. Patrick Trévidic brings more than 35 years of experience spanning aesthetic surgery, scientific research and anatomy-based education. His contributions include clinical investigation, international teaching, more than 75 peer-reviewed publications and internationally recognized textbooks.
By combining MOYOM's calcium hydroxyapatite technology with Expert2Expert's scientific expertise, this collaboration creates a framework centered on evidence, education and clinical advancement.
